Key result
The clinical utility and cost-effectiveness of high-risk diagnostic and therapeutic strategies guided by subclinical arterial disease remain untested for primary prevention.
Why the study?
Does non-invasive detection of subclinical arterial disease improve cardiovascular disease risk evaluation and risk-reduction therapy in asymptomatic individuals without clinically overt cardiovascular disease?
Population
Asymptomatic individuals without clinically overt cardiovascular disease, particularly those judged to be at…
Comparison
Non-invasive detection of subclinical arterial… vs Traditional risk factor assessment alone
Design
Review
Authors
Loading...
Should not yet guide primary prevention; leaves open whether subclinical arterial disease detection refines risk evaluation or therapy.
Does non-invasive detection of subclinical arterial disease improve cardiovascular disease risk evaluation and risk-reduction therapy in asymptomatic individuals without clinically overt cardiovascular disease?
While non-invasive detection of subclinical arterial disease may help refine risk assessment in intermediate-risk asymptomatic individuals, its clinical utility and cost-effectiveness remain untested for routine primary prevention.
Simon et al. (2005) conducted a review in Cardiovascular disease risk. Non-invasive detection of subclinical arterial disease vs. Traditional risk factors was evaluated. The clinical utility and cost-effectiveness of high-risk diagnostic and therapeutic strategies guided by subclinical arterial disease remain untested for primary prevention.